Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,011 across all filing types
Latest filing 2022-12-15 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
第六届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first meeting of the sixth supervisory board of Kangzhi Pharmaceutical Co., Ltd. It includes the election of the chairman of the supervisory board and a brief biography of the elected chairman. The content focuses on board/management changes and governance matters rather than financial results, audit, or general meeting materials. The document length is short (1141 characters) and it is a formal announcement of a board-related decision. Therefore, it fits best under Board/Management Information (MANG).
2022-12-15 Chinese
关于召开2022年第一次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2022 first extraordinary general meeting of shareholders for 康芝药业股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items including board and supervisory committee elections, and instructions for shareholder registration and proxy voting. The document does not contain financial statements or results but focuses on the organization and conduct of a shareholder meeting. It is not a full annual or interim report, nor an earnings release or audit report. It is not a voting results announcement but a notice about the meeting itself. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2022-12-12 Chinese
独立董事提名人声明（郑欢雪）
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It contains detailed declarations about the nominee's qualifications and compliance with various regulatory requirements. There are no financial statements, earnings data, or report attachments. The document is a formal announcement related to board/management changes, specifically the nomination of a new independent director. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3236 characters, which is consistent with a detailed announcement rather than a full report.
2022-11-28 Chinese
独立董事提名人声明（张继承）
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications and compliance with various regulatory requirements. There is no financial data, no report of financial performance, no voting results, no meeting materials, and no mention of any report publication. The content is related to board/management information, specifically about a nomination for a board position. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 3236 characters, which is relatively short but contains substantive content about management nomination rather than a mere announcement or certification.
2022-11-28 Chinese
独立董事提名人声明（吴清和）
Board/Management Information Classification · 95% confidence The document is a formal public statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information, specifically the nomination of a board member. The document length is 3236 characters, which is relatively short and consistent with a nomination announcement rather than a full report. Therefore, the document fits best under the category of Board/Management Information (MANG).
2022-11-28 Chinese
第五届监事会第二十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the supervisory board (监事会) of 康芝药业股份有限公司 regarding the election of new supervisory board members. It details the meeting date, attendance, voting results, and next steps for shareholder approval. There is no financial data, no mention of annual or quarterly reports, no audit information, no earnings data, and no regulatory certifications. The content focuses on board/management changes specifically related to the supervisory board election. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2022-11-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.